AbCellera Biologics
ABCL
ABCL
146 hedge funds and large institutions have $338M invested in AbCellera Biologics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 47 reducing their positions, and 26 closing their positions.
Holders
146
Holders Change
-8
Holders Change %
-5.19%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
20
Increased
37
Reduced
47
Closed
26
Calls
$1.08M
Puts
$1.16M
Net Calls
-$73K
Net Calls Change
+$784K
Top Buyers
| 1 |
1
UBS AM
Chicago,
Illinois
|
$13.6M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$4.36M |
| 3 |
3
Two Sigma Investments
New York
|
$6.1M |
| 4 |
PM
4
Prosight Management
Dallas,
Texas
|
$6.96M |
| 5 |
EAM
5
Exome Asset Management
New York
|
$1.52M |
